NCT06877572 Weight Loss Management in Endometrial Cancer Survivors
| NCT ID | NCT06877572 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Kansas Medical Center |
| Condition | Endometrial Cancer Survivors |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-03-25 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-03-25 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to understand how oncologists can engage a multidisciplinary team to help endometrial cancer survivors with obesity to engage in a weight management program and potentially start a weight loss medication. Obesity often impacts the future health and longevity of early-stage endometrial cancer survivors more than their cancer diagnosis. Patients will be referred to the KUMC OB/Gyn weight management clinic to discuss weight management options. * If patients decide to use medications for weight loss, then the study will collect data from their chart that is recorded as part of routine monitoring for patients on weight loss medications. * If patients decide not to use any medications, the study will monitor physical exam and lab data collected as part of their routine medical care. The study will also try to understand reasons why patients did or did not start using a weight loss medication.
Eligibility Criteria
Inclusion Criteria: * ≥18 years old * ECOG 0-2 * BMI ≥ 30kg/m2 * Completed surgical staging with no evidence of residual disease * Endometrioid endometrial adenocarcinoma, p53 wild type * Stage 1 * Undergoing active surveillance +/- brachytherapy Exclusion Criteria: * Unable to participate in behavior weight loss * Stroke, heart attack, end stage liver disease, or end stage kidney disease during the last 6 months. * Currently on a GLP-1 agonist * Currently on insulin
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06877572 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Endometrial Cancer Survivors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06877572 currently recruiting?
Yes, NCT06877572 is actively recruiting participants. Contact the research team at mjavellana@kumc.edu for enrollment information.
Where is the NCT06877572 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT06877572 clinical trial?
NCT06877572 is sponsored by University of Kansas Medical Center. The trial plans to enroll 50 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.